Evidence map›Paper›PMID 36203381›Full record

ArticleCell biochemistry and function2022

Inhibition of nonstructural protein 15 of SARS-CoV-2 by golden spice: A computational insight.

Rahul Singh, Vijay K Bhardwaj, Rituraj Purohit

Abstract read
In one paragraph

Article in Cell biochemistry and function, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 49 papers.

0numbers the graph read from it
0cells of the map it votes in
49citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

49 citing papers in PubMed.

  1. Article
  2. Article
  3. Phenol and chromone compounds forPharmaceutical science advances · 2025
    Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Rahul SinghStructural Bioinformatics Lab, CSIR-Institute of Himalayan Bioresource Technology (CSIR-IHBT), The Himalayan Centre for High-throughput Computational Biology (HiCHiCoB, A BIC Supported by DBT), Palampur, India.
Vijay K BhardwajStructural Bioinformatics Lab, CSIR-Institute of Himalayan Bioresource Technology (CSIR-IHBT), The Himalayan Centre for High-throughput Computational Biology (HiCHiCoB, A BIC Supported by DBT), Palampur, India.
Rituraj PurohitStructural Bioinformatics Lab, CSIR-Institute of Himalayan Bioresource Technology (CSIR-IHBT), The Himalayan Centre for High-throughput Computational Biology (HiCHiCoB, A BIC Supported by DBT), Palampur, India.ORCID http://orcid.org/0000-0002-2101-9398

Funding

Council of Scientific and Industrial Research, India 0201Council of Scientific and Industrial Research, India MLP
6 · The paper itself

Abstract

The quick widespread of the coronavirus and speedy upsurge in the tally of cases demand the fast development of effective drugs. The uridine-directed endoribonuclease activity of nonstructural protein 15 (Nsp15) of the coronavirus is responsible for the invasion of the host immune system. Therefore, developing potential inhibitors against Nsp15 is a promising strategy. In this concern, the in silico approach can play a significant role, as it is fast and cost-effective in comparison to the trial and error approaches of experimental investigations. In this study, six turmeric derivatives (curcuminoids) were chosen for in silico analysis. The molecular interactions, pharmacokinetics, and drug-likeness of all the curcuminoids were measured. Further, the stability of Nsp15-curcuminoids complexes was appraised by employing molecular dynamics (MD) simulations and MM-PBSA approaches. All the molecules were affirmed to have strong interactions and pharmacokinetic profile. The MD simulations data stated that the Nsp15-curcuminoids complexes were stable during simulations. All the curcuminoids showed stable and high binding affinity, and these curcuminoids could be admitted as potential modulators for Nsp15 inhibition.

Indexed as

COVID-19Viral Nonstructural ProteinsAntiviral AgentsEndoribonucleasesHumansMolecular Docking SimulationMolecular Dynamics SimulationSARS-CoV-2Antiviral AgentsEndoribonucleasesViral Nonstructural Proteinsboiled-eggmolecular dynamicsNsp15 endoribonucleaseSARS-CoV-2

Identifiers

PMID36203381
PMCPMC9874790

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.